Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Malaria in Mauritania: retrospective and prospective overview.

Lekweiry KM, Salem MS, Basco LK, Briolant S, Hafid J, Boukhary AO.

Malar J. 2015 Mar 4;14(1):100. doi: 10.1186/s12936-015-0607-5.

2.

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.

Pascual A, Madamet M, Briolant S, Gaillard T, Amalvict R, Benoit N, Travers D, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2015 Feb 5;14(1):49. doi: 10.1186/s12936-015-0586-6.

3.

Mosquito magnet® liberty plus trap baited with octenol confirmed best candidate for Anopheles surveillance and proved promising in predicting risk of malaria transmission in French Guiana.

Vezenegho SB, Adde A, Gaborit P, Carinci R, Issaly J, Pommier de Santi V, Dusfour I, Briolant S, Girod R.

Malar J. 2014 Sep 26;13:384. doi: 10.1186/1475-2875-13-384.

4.

Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy.

Ibrahim N, Ibrahim H, Dormoi J, Briolant S, Pradines B, Moreno A, Mazier D, Legrand P, Nepveu F.

Int J Pharm. 2014 Apr 10;464(1-2):214-24. doi: 10.1016/j.ijpharm.2014.01.001. Epub 2014 Jan 8.

PMID:
24412521
5.

PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.

Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2013 Nov 14;12:414. doi: 10.1186/1475-2875-12-414.

6.

Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.

Dormoi J, Briolant S, Pascual A, Desgrouas C, Travaillé C, Pradines B.

Malar J. 2013 Aug 30;12:302. doi: 10.1186/1475-2875-12-302.

7.

[Delayed diagnosis of Plasmodium falciparum in a soldier in Uganda: false-positive rapid diagnostic test associated with reduced repeats in pfhrp2].

Wurtz N, Briolant S, Lemarié D, Pommier de Santi V, Pascual A, Roodt T, Benoit N, Hupin C, Pradines B.

Med Sante Trop. 2013 May 1;23(2):181-4. doi: 10.1684/mst.2013.0171. French.

PMID:
23774584
8.

Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti.

Khaireh BA, Assefa A, Guessod HH, Basco LK, Khaireh MA, Pascual A, Briolant S, Bouh SM, Farah IH, Ali HM, Abdi AI, Aden MO, Abdillahi Z, Ayeh SN, Darar HY, Koeck JL, Rogier C, Pradines B, Bogreau H.

Malar J. 2013 Jun 13;12:201. doi: 10.1186/1475-2875-12-201.

9.

In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal.

Pascual A, Fall B, Wurtz N, Fall M, Camara C, Nakoulima A, Baret E, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Bogreau H, Briolant S, Rogier C, Wade B, Pradines B.

Malar J. 2013 Jun 7;12:189. doi: 10.1186/1475-2875-12-189.

10.

Plasmodium falciparum with multidrug resistance 1 gene duplications, Senegal.

Pascual A, Fall B, Wurtz N, Fall M, Camara C, Nakoulima A, Baret E, Diatta B, Wade B, Briolant S, Pradines B.

Emerg Infect Dis. 2013 May;19(5):814-5. doi: 10.3201/eid1905.121603. No abstract available.

11.

Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.

Dormoi J, Briolant S, Desgrouas C, Pradines B.

Antimicrob Agents Chemother. 2013 Jul;57(7):3412-4. doi: 10.1128/AAC.02381-12. Epub 2013 Apr 22.

12.

Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.

Dormoi J, Briolant S, Desgrouas C, Pradines B.

Malar J. 2013 Apr 15;12:127. doi: 10.1186/1475-2875-12-127.

13.

Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.

Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, Diémé Y, Briolant S, Bercion R, Wade B, Tall A, Pradines B.

Malar J. 2013 Mar 20;12:107. doi: 10.1186/1475-2875-12-107.

14.

Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests.

Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Wade B, Briolant S, Pradines B.

Malar J. 2013 Jan 24;12:34. doi: 10.1186/1475-2875-12-34.

15.

Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants.

Khaireh BA, Briolant S, Pascual A, Mokrane M, Machault V, Travaillé C, Khaireh MA, Farah IH, Ali HM, Abdi AI, Ayeh SN, Darar HY, Ollivier L, Waiss MK, Bogreau H, Rogier C, Pradines B.

Malar J. 2012 Nov 28;11:395. doi: 10.1186/1475-2875-11-395.

16.

Anopheles salivary gland proteomes from major malaria vectors.

Fontaine A, Fusaï T, Briolant S, Buffet S, Villard C, Baudelet E, Pophillat M, Granjeaud S, Rogier C, Almeras L.

BMC Genomics. 2012 Nov 13;13:614. doi: 10.1186/1471-2164-13-614.

17.

Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.

Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Diémé Y, Rogier C, Bercion R, Briolant S, Wade B, Pradines B.

Malar J. 2012 Jun 13;11:197. doi: 10.1186/1475-2875-11-197.

18.

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.

Wurtz N, Pascual A, Marin-Jauffre A, Bouchiba H, Benoit N, Desbordes M, Martelloni M, Pommier de Santi V, Richa G, Taudon N, Pradines B, Briolant S.

Malar J. 2012 May 2;11:146.

19.

Absence of association between ex vivo susceptibility to doxycycline and pftetQ and pfmdt copy numbers in Plasmodium falciparum isolates from Dakar, Senegal.

Gaillard T, Fall B, Tall A, Wurtz N, Diatta B, Lavina M, Fall KB, Sarr FD, Baret E, Diémé Y, Wade B, Bercion R, Briolant S, Pradines B.

Clin Microbiol Infect. 2012 Jul;18(7):E238-40. doi: 10.1111/j.1469-0691.2012.03889.x. Epub 2012 Apr 25.

20.

Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.

Dormoi J, Pascual A, Briolant S, Amalvict R, Charras S, Baret E, Huyghues des Etages E, Feraud M, Pradines B.

Antimicrob Agents Chemother. 2012 Jun;56(6):3467-9. doi: 10.1128/AAC.06073-11. Epub 2012 Mar 5. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk